Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study.
Azad NS, El-Khoueiry A, Yin J, Oberg AL, Flynn P, Adkins D, Sharma A, Weisenberger DJ, Brown T, Medvari P, Jones PA, Easwaran H, Kamel I, Bahary N, Kim G, Picus J, Pitot HC, Erlichman C, Donehower R, Shen H, Laird PW, Piekarz R, Baylin S, Ahuja N.
Azad NS, et al. Among authors: weisenberger dj.
Oncotarget. 2017 May 23;8(21):35326-35338. doi: 10.18632/oncotarget.15108.
Oncotarget. 2017.
PMID: 28186961
Free PMC article.
Clinical Trial.